Johnson & Johnson (NYSE:JNJ) has agreed to pay $99 million to put opioid-related claims in the State of West Virginia to bed.  The state has removed J&J from an ongoing trial in Kanawha County.  West Virginia’s attorney general, Patrick Morrisey, concluded that state’s decision not to join a nationwide settlement was worthwhile because the state received…

The Oklahoma State Supreme Court has overturned a 2019 opioid judgment against Johnson & Johnson (NYSE:JNJ) amounting to $465 million. Five of the six Oklahoma Supreme Court’s justices dismissed the state’s case claiming that Johnson & Johnson breached its “public nuisance” laws in its marketing of prescription opioid drugs. “Oklahoma public nuisance law does not…